ChangXin's "Peer": The Fate of Fujian Jinhua Integrated Circuit Co., Ltd. Is Regrettable
China's DRAM industry saw a pivotal moment with ChangXin's (CXMT) successful IPO. However, the fate of its 2016 counterpart, Fujian Jinhua Integrated Circuit, offers a stark contrast. Both were founded the same year with similar missions, massive investment, and 12-inch wafer fab goals to break into the DRAM market dominated by Samsung, SK Hynix, and Micron.
Fujian Jinhua initially progressed faster by partnering with Taiwan's United Microelectronics Corporation (UMC) for 32nm DRAM technology. This strategy, however, led to a protracted legal battle. In 2017, Micron sued UMC and Jinhua for trade secret theft. The situation escalated in October 2018 when the U.S. Commerce Department added Fujian Jinhua to its Entity List, citing its imminent mass production as a threat. This resulted in an immediate halt of equipment, software, and technical support from American suppliers, followed by UMC suspending cooperation. Although Jinhua was eventually cleared of criminal charges in late 2023 after a nearly six-year legal saga, it missed the critical industry growth window.
In contrast, ChangXin took a different path from the start, focusing on building its own R&D system and securing intellectual property, notably through a license for former Qimonda patents. While also facing U.S. scrutiny and initial heavy losses, ChangXin benefited from a more mature domestic supply chain when it reached mass production. It achieved profitability in 2025 and represents the rise of China's DRAM industry.
Jinhua's story is a crucial lesson. It was the first Chinese DRAM company to confront the complex realities of international IP disputes, export controls, and supply chain vulnerabilities. Today, it has resumed operations with a 40,000 wafers-per-month capacity, aiming for 60,000. While it missed its initial opportunity, its experience informed the strategic evolution of later Chinese semiconductor firms.
marsbit31 хв тому
